Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (108)

2024

  1. Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support

    Open Respiratory Archives, Vol. 6, Núm. 2

  2. Spanish Consensus on Remission in Asthma (REMAS)

    Archivos de Bronconeumologia

  3. The effect of biologics in lung function and quality of life of patients with united airways disease: A systematic review

    Journal of Allergy and Clinical Immunology: Global, Vol. 3, Núm. 1

  4. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  3. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  5. Diagnosis and Treatment of Pleural Effusion. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery. Update 2022

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 27-35

  6. Exacerbations in COPD: a personalised approach to care

    The Lancet Respiratory Medicine

  7. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  8. Quality indicators in the rational management of severe asthma: A Spanish multidisciplinary consensus

    Journal of Healthcare Quality Research, Vol. 38, Núm. 5, pp. 277-283

  9. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  10. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

  11. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

  12. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

  13. Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain

    Open Respiratory Archives, Vol. 5, Núm. 3

  14. What's New in the 2022 Consensus for Severe Asthma in Adults

    Archivos de Bronconeumologia

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. ANTES Program: One Year on

    Archivos de Bronconeumologia